Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Aptinyx Inc (NQ: APTX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 18, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aptinyx Inc

< Previous 1 2 3 4 5 6 Next >
Aptinyx to Participate in H.C. Wainwright 1st Annual Mental Health Conference
From Aptinyx Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
During Friday's trading, 69 companies set new 52-week lows. 
Via Benzinga
Expert Ratings for Aptinyx
Within the last quarter, Aptinyx (NASDAQ:APTX) has observed the following analyst ratings: 
Via Benzinga
Expert Ratings for Aptinyx
Within the last quarter, Aptinyx (NASDAQ:APTX) has observed the following analyst ratings: 
Via Benzinga
Aptinyx: Q4 Earnings Insights
Aptinyx (NASDAQ:APTX) reported its Q4 earnings results on Wednesday, March 23, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Aptinyx... 
Via Benzinga
Aptinyx to Participate in H.C. Wainwright Global Investment Conference
From Aptinyx Inc.
Via Business Wire
Aptinyx Announces Poster Presentation Highlighting Preclinical Data on NYX-783 in Models of PTSD at the 2022 American Psychiatric Association Annual Meeting
From Aptinyx Inc.
Via Business Wire
Recap: Aptinyx Q1 Earnings
Aptinyx (NASDAQ:APTX) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Aptinyx beat estimated earnings by... 
Via Benzinga
Aptinyx Reports First Quarter 2022 Financial Results and Highlights Recent Clinical Progress
From Aptinyx Inc.
Via Business Wire
Earnings Preview For Aptinyx
Aptinyx (NASDAQ:APTX) is set to give its latest quarterly earnings report on Wednesday, 2022-03-23. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
90 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Aptinyx Presents Preclinical Data on NYX-783 in Models of PTSD at 2022 Society of Biological Psychiatry Annual Meeting
From Aptinyx Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Aptinyx to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
From Aptinyx Inc.
Via Business Wire
26 Stocks Moving in Thursday's Pre-Market Session
Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) rose 31.9% to $3.35 in pre-market trading after jumping around 25% on Wednesday. Clarus Therapeutics Holdings, Inc. (NASDAQ:... 
Via Benzinga
Aptinyx Announces Publication in Molecular Psychiatry Demonstrating Reduction of Spontaneous Recovery of Fear with NYX-783
From Aptinyx Inc.
Via Business Wire
53 Biggest Movers From Yesterday
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail... 
Via Benzinga
Mid-Afternoon Market Update: S&P 500 Turns Positive; Aptinyx Shares Slide
  U.S. stocks pared losses, with the Dow Jones and S&P 500 turning positive toward the end of trading on Thursday. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Trevi Therapeutics (NASDAQ:TRVI) stock rose 45.8% to $2.77 during Thursday's regular session. Trevi Therapeutics's stock is trading at a volume of 15.2... 
Via Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) jumped 57.6% to $1.3515. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average price... 
Via Benzinga
Mid-Day Market Update: Dow Tumbles Over 200 Points; Momentus Shares Jump
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Thursday. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers IMAC Holdings (NASDAQ:IMAC) shares increased by 60.0% to $1.6 during Thursday's pre-market session. The market value of their outstanding shares is at $41.9 million. 
Via Benzinga
Mid-Morning Market Update: Markets Mixed; US Jobless Claims Fall Last Week
U.S. stocks traded mixed this morning, with the Dow Jones dropping around 150 points on Thursday. 
Via Benzinga
Aptinyx Shares Tank On Disappointed Data From Mid-Stage Diabetic Peripheral Neuropathy Study
Aptinyx Inc (NASDAQ: APTX) shares are plunging after results from a Phase 2b study of NYX-2925 in patients with painful diabetic peripheral neuropathy (DPN).  
Via Benzinga
The Daily Biotech Pulse: Pfizer Goes Shopping, AstraZeneca Inks Bispecific Antibody Deal, Aptinyx Faces Clinical Study Setback, Erytech Jumps On Data And More
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Aptinyx Reports Results from Phase 2b Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy
From Aptinyx Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) stock increased by 26.3% to $1.73 during Thursday's regular session. The current volume of 55.2 million shares is 5751.8... 
Via Benzinga
Aptinyx Reports Fourth Quarter and Full Year 2021 Results and Highlights
From Aptinyx Inc.
Via Business Wire
The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Earnings Scheduled For March 23, 2022
Companies Reporting Before The Bell • AYRO (NASDAQ:AYRO) is expected to report earnings for its fourth quarter. • First Trust NASDAQ Clean Edge Smart Grid... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.